Ulcerative Colit.
Conditions
Interventions
Intervention 1: Intervention group: 22 patients with ulcerative colitis who will receive two supplements of pomegranate supplements containing 225 mg of dried pomegranate extract for 8 weeks daily aft
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Disease diagnosed by a Gastroenterologist The patient's medical condition has been stable for the past two months The desire to participate in the study
Exclusion criteria
Exclusion criteria: Sensitivity to pomegranate or its products Pregnancy Lactation Taking steroid drugs, other experimental drugs, and probiotics Kidney, heart and hepatitis Taking other nutritional supplements Having a special diet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-6. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;IL-10. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;TNF-alpha. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;Hs-CRP. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;ANCA. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;Fecal Calprotectin. Timepoint: The beginning and end of the study. Method of measurement: laboratory test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: The beginning and end of the study. Method of measurement: IBDQ-9 questionaire.;Severity of symptoms. Timepoint: The beginning and end of the study. Method of measurement: SCCAI questionair.;Antropometric Index. Timepoint: The beginning and end of the study. Method of measurement: Body measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Keramati
Tabriz University of Medical Sciences
Outcome results
None listed